Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology
- 1 January 2007
- journal article
- biotechnological products-and-process-engineering
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 73 (5) , 1054-1058
Abstract
Lovastatin, an inhibitor of HMG-CoA reductase, was produced by submerged fermentation using Monascus purpureus MTCC 369. Five nutritional parameters screened using Plackett–Burman experimental design were optimized by Box–Behnken factorial design of response surface methodology for lovastatin production in shake flask cultures. Maximum lovastatin production of 351 mg/l were predicted in medium containing 29.59 g/l dextrose, 3.86 g/l NH4Cl, 1.73 g/l KH2PO4, 0.86 g/l MgSO4·7H2O, and 0.19 g/l MnSO4·H2O using response surface plots and point prediction tool of DESIGN EXPERT 7.0 (Statease, USA) software.Keywords
This publication has 13 references indexed in Scilit:
- Statistical optimization of medium components for the production of Antrodia cinnamomea AC0623 in submerged culturesApplied Microbiology and Biotechnology, 2006
- Lovastatin and beyond: the history of the HMG-CoA reductase inhibitorsNature Reviews Drug Discovery, 2003
- Production of the secondary metabolites γ-aminobutyric acid and monacolin K by MonascusJournal of Industrial Microbiology and Biotechnology, 2003
- Optimization of compactin production in chemically defined production medium by Penicillium citrinum using statistical methodsProcess Biochemistry, 2002
- Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugsApplied Microbiology and Biotechnology, 2002
- Lovastatin Biosynthesis by Aspergillus terreus in a Chemically Defined MediumApplied and Environmental Microbiology, 2001
- Production of statins by filamentous fungiBiotechnology Letters, 1999
- Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total MortalityJAMA, 1997
- Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.Proceedings of the National Academy of Sciences, 1980
- Multi-Factor Experimental Designs for Exploring Response SurfacesThe Annals of Mathematical Statistics, 1957